- cafead Jun 07, 2024 at 11:32: AM
via Shares of Geron (GERN.O) surged more than 30% on Friday, a day after the company gained its first approval from the U.S. Food and Drug Administration for its blood disorder drug.
The health regulator's nod allows the injectable drug, branded as Rytelo, to be used for treating transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromes (MDS), a group of blood cancers.
article source
The health regulator's nod allows the injectable drug, branded as Rytelo, to be used for treating transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromes (MDS), a group of blood cancers.
article source